Author: Bin Lou; Tigndong Li; Shufa Zheng; Yingying Su; Zhiyong Li; Wei Liu; Fei Yu; Shengxiang Ge; Qianda Zou; Quan Yuan; Sha Lin; Congming Hong; Xiangyang Yao; Xuejie Zhang; Dinghui Wu; Guoliang Zhou; Wangheng Hou; Tingting Li; Yali Zhang; Shiyin Zhang; Jian Fan; Jun Zhang; Ningshao Xia; Yu Chen
Title: Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset Document date: 2020_3_27
ID: ndpuezpo_33
Snippet: The present study showed that near all (98.8%, 79/80) Covid-19 patients converted to be seropositive during the illness course. Seroconversion was first observed on 7d.p.e (2d.p.o). The first detectible antibody is total antibody and followed by IgM and IgG, with a median seroconversion time of 15d.p.e (9d.p.o), 18d.p.e (10d.p.o) and 20d.p.e (12d.p.o). It is very similar as that observed in SARS-CoV-1 infection. [16, 17] Interestingly, the rising.....
Document: The present study showed that near all (98.8%, 79/80) Covid-19 patients converted to be seropositive during the illness course. Seroconversion was first observed on 7d.p.e (2d.p.o). The first detectible antibody is total antibody and followed by IgM and IgG, with a median seroconversion time of 15d.p.e (9d.p.o), 18d.p.e (10d.p.o) and 20d.p.e (12d.p.o). It is very similar as that observed in SARS-CoV-1 infection. [16, 17] Interestingly, the rising of antibody levels accompanied with the decline of viral load.
Search related documents:
Co phrase search for related documents- antibody level and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- antibody level and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- antibody level and seroconversion time: 1, 2, 3
- antibody level and total antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- antibody level and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- detectible antibody and median seroconversion time: 1
- detectible antibody and SARS infection: 1
- detectible antibody and seroconversion time: 1
- detectible antibody and total antibody: 1
- detectible antibody and viral load: 1
- detectible antibody and viral load decline: 1
- IgG IgM follow and SARS infection: 1
- IgG IgM follow and total antibody: 1
- illness course and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- illness course and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- illness course and viral load: 1, 2, 3, 4, 5, 6, 7
- median seroconversion time and present study: 1
- median seroconversion time and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8
- median seroconversion time and seroconversion time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
Co phrase search for related documents, hyperlinks ordered by date